BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29743303)

  • 1. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
    Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of enzyme immunoassays and rapid diagnostic tests for clostridium difficile glutamate dehydrogenase and toxin a + B to toxinogenic culture on a highly selective chromogenic medium.
    Olling A; Leidinger H; Hoffmann R
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1655-9. PubMed ID: 27323765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.
    Banz A; Lantz A; Riou B; Foussadier A; Miller M; Davies K; Wilcox M
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the diagnostic algorithm consisting of enzyme immunoassay for toxins and polymerase chain reaction, for the diagnosis of Clostridium difficile-associated diarrhoea.
    Lee JH; Park SJ; Lee YM; Lee CH; Cho JH
    Scand J Infect Dis; 2012 Dec; 44(12):969-72. PubMed ID: 22813084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
    Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
    Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
    Baker I; Leeming JP; Reynolds R; Ibrahim I; Darley E
    J Hosp Infect; 2013 Aug; 84(4):311-5. PubMed ID: 23831282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection diagnostics - evaluation of the C. DIFF Quik Chek Complete assay, a rapid enzyme immunoassay for detection of toxigenic C. difficile in clinical stool samples.
    Johansson K; Karlsson H; Norén T
    APMIS; 2016 Nov; 124(11):1016-1020. PubMed ID: 27651167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile.
    Qutub MO; AlBaz N; Hawken P; Anoos A
    Indian J Med Microbiol; 2011; 29(3):293-6. PubMed ID: 21860113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
    Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
    Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile colitis: an efficient clinical approach to diagnosis.
    Manabe YC; Vinetz JM; Moore RD; Merz C; Charache P; Bartlett JG
    Ann Intern Med; 1995 Dec; 123(11):835-40. PubMed ID: 7486465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes of
    Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage algorithm for Clostridium difficile: glutamate-dehydrogenase-positive toxin-negative enzyme immunoassay results may require further testing.
    Bignardi GE; Hill K; Berrington A; Settle CD
    J Hosp Infect; 2013 Apr; 83(4):347-9. PubMed ID: 23399483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.
    Origüen J; Corbella L; Orellana MÁ; Fernández-Ruiz M; López-Medrano F; San Juan R; Lizasoain M; Ruiz-Merlo T; Morales-Cartagena A; Maestro G; Parra P; Villa J; Delgado R; Aguado JM
    Clin Microbiol Infect; 2018 Apr; 24(4):414-421. PubMed ID: 28811244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.
    Patel H; Randhawa J; Nanavati S; Marton LR; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2015; 45(3):333-9. PubMed ID: 26116599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
    Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.